🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 8 of 39

  1. Ceftolozane/tazobactam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Bronchiectasis

    approved small molecule active

    1 trial

  2. Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial

  3. Celecoxib

    Pfizer

    Arthritis, Juvenile Rheumatoid

    approved small molecule completed

    1 trial

  4. Celestone Cronodose suspensión inyectable, Plasma rich in growth factors

    Wuhan Createrna Science and Technology Co., Ltd

    Low back pain

    approved small molecule active

    1 trial

  5. Cellular Matrix / A-CP-HA Kit

    Regeneron Ireland Designated Activity Company (DAC)

    Genitourinary Syndrome of Menopause

    approved small molecule active

    1 trial

  6. Cetrorelix Acetate

    United Therapeutics Europe Ltd

    Infertility

    approved small molecule active

    1 trial

  7. Chemoembolization and Response-Dependent Resection

    The First People's Hospital of Lianyungang

    Resectable Hepatocellular Carcinoma Beyond Milan Criteria

    approved other active

    1 trial

  8. Chinese Herb Huang-Chi-Wu-Wu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracranial Arterial Stenosis

    approved small molecule active

    1 trial

  9. Chlorhexidine

    United Therapeutics Europe Ltd

    Pneumonia

    approved other completed

    1 trial

  10. Chlorhexidine

    CRESCENT BIOPHARMA, INC.

    Neonatal Infections

    approved small molecule completed

    1 trial

  11. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved small molecule completed

    1 trial

  12. Chloroprocaine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    approved small molecule completed

    1 trial

  13. Chloroquine

    United Therapeutics Europe Ltd

    Malaria, Falciparum

    approved small molecule completed

    1 trial

  14. Chocolate PTA Balloon

    Blackmores Limited

    Atherosclerosis

    approved other active

    1 trial

  15. Cholecalciferol

    United Therapeutics Europe Ltd

    Crohn Disease

    approved other active

    1 trial

  16. Cholecalciferol

    The First People's Hospital of Lianyungang

    Peritoneal Dialysis-associated Peritonitis

    approved small molecule active

    1 trial

  17. Ciclesonide

    Takeda

    Allergic Rhinitis

    approved small molecule completed

    1 trial

  18. Cilostazol

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Disease

    approved small molecule active

    1 trial

  19. Cilostazol

    Otsuka Beijing Research Institute

    Polyneuropathy

    approved small molecule completed

    1 trial

  20. Cilostazol

    Otsuka Beijing Research Institute

    Cerebral Infarction

    approved small molecule completed

    1 trial

  21. Cinacalcet

    The University of Hong Kong

    Kidney Failure

    approved small molecule completed

    1 trial

  22. Cinacalcet HCl

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperparathyroidism; Secondary, Renal

    approved small molecule completed

    1 trial

  23. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved small molecule active

    1 trial

  24. Ciprofloxacin

    Iterum Therapeutics plc

    UTI - Lower Urinary Tract Infection

    approved small molecule completed

    1 trial

  25. Ciprofol

    The First People's Hospital of Lianyungang

    Postoperative Delirium (POD)

    approved small molecule active

    1 trial

  26. Ciprofol

    The First People's Hospital of Lianyungang

    ECMO Treatment

    approved small molecule active

    1 trial

  27. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial

  28. Citrate anticoagulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  29. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  30. Clopidogrel

    Evidence Based Cataract Study Group

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  31. Clopidogrel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  32. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  33. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  34. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  35. Cocaine-Related Disorders

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    2 trials

  36. Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses

    The First People's Hospital of Lianyungang

    HER2 Positive Breast Cancer

    approved small molecule active

    1 trial

  37. Colchicine

    Takeda

    Pharmacokinetics

    approved small molecule completed

    1 trial

  38. Colchicine

    Takeda

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  39. Colchicine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    In-stent Restenosis

    approved small molecule active

    1 trial

  40. Colchicine (Colcrys®)

    Regeneron UK Limited

    Intercritical Gout

    approved small molecule completed

    1 trial

  41. Colla corii asini

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thalassemia

    approved small molecule active

    1 trial

  42. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  43. Combination Cinacalcet with Vitamin D analogue

    Hospital Authority, Hong Kong

    Secondary Hyperparathyroidism

    approved small molecule active

    1 trial

  44. Combination NRT (Nicotine patch, Nicotine lozenge)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  45. Combination of antiplatelet drugs and anticoagulants for at least one month

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  46. Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial

  47. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  48. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.